Dithiocarbamate prodrugs activated by prostate specific antigen to target prostate cancer.
Dithiocarbamate prodrugs activated by prostate specific antigen to target prostate cancer.
复制标题
DOI:
10.1016/j.bmcl.2020.127148
复制
发表时间:
2020-06-01
影响因子:
2.7
通讯作者:
Franz KJ
中科院分区:
文献类型:
--
作者:
Bakthavatsalam S;Wiangnak P;George DJ;Zhang T;Franz KJ
Disulfiram in conjunction with copper has been shown to be a potent anticancer agent. However, disulfiram’s therapeutic potential in prostate cancer is hindered by off-target effects due to its reactive and nucleophilic thiol-containing component, diethyldithiocarbamate (DTC). To minimize undesirable reactivity, we have strategically blocked the thiol moiety in DTC with a cleavable p-aminobenzyl (pAB) group linked to peptide substrates recognized by prostate specific antigen (PSA). Here we report the synthesis and evaluation in cancer cell models of two PSA-activatable prodrugs: HPD (Ac-HSSKLQL-pAB-DTC and RPD (RSSYYSL-pAB-DTC). In vitro exposure to PSA was found to trigger activation of HPD and RPD to release diethyldithiocarbamate, and both prodrugs were found to induce toxicity in prostate cancer cells, with HPD showing the most promising selectivity. With copper supplementation, the IC50 of HPD was 1.4 μM in PSA-expressing LNCaP cells, and 11 μM in PC3 cells that do not express PSA. These studies demonstrate the utility of using peptide recognition handles to direct the activity of dithiocarbamate prodrugs for selective cytotoxicity of cancer cells.
登录
查看更多内容
影响因子:
3.5
作者:
AKIYAMA, K;NAKAMURA, T;HARA, M
通讯作者:
HARA, M
影响因子:
158.5
作者:
Scher, Howard I.;Fizazi, Karim;de Bono, Johann S.
通讯作者:
de Bono, Johann S.
影响因子:
--
作者:
Denoyer D;Pearson HB;Clatworthy SA;Smith ZM;Francis PS;Llanos RM;Volitakis I;Phillips WA;Meggyesy PM;Masaldan S;Cater MA
通讯作者:
Cater MA
影响因子:
158.5
作者:
STAMEY, TA;YANG, N;REDWINE, E
通讯作者:
REDWINE, E
影响因子:
15.9
作者:
LILJA, H
通讯作者:
LILJA, H